Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$12.9M Buy
678,100
+100,000
+17% +$2.21M 0.5% 73
2019
Q1
$16.4M Buy
578,100
+78,100
+16% +$2.28M 0.68% 62
2018
Q4
$13.7M Buy
500,000
+135,000
+37% +$4.37M 0.62% 54
2018
Q3
$13.4M Buy
365,000
+216,000
+145% +$8.11M 0.56% 68
2018
Q2
$5.38M Sell
149,000
-185,700
-55% -$7.29M 0.23% 126
2018
Q1
$13.8M Buy
+334,700
New +$14.3M 0.71% 43
2017
Q4
Hold
0
22

Other funds holding VTRS

Delek Group's VTRS Position: Q2 2019 in Review

Delek Group reduced its Viatris (VTRS) stake by 0.67% in Q2 2019, selling an estimated $411K and leaving 2,775,111 shares worth $51.6M. The position accounts for 2% of the portfolio, ranked #5.

Delek Group first reported a position in VTRS in Q4 2017 and has held it in 7 quarters since. The position peaked at $105M in Q3 2018. 439 funds tracked by Wall St. Rank hold VTRS as of Q2 2019.

  • Delek Group held 2,775,111 shares of Viatris worth $51.6M as of Q2 2019.
  • Delek Group sold 18,600 Viatris shares in Q2 2019, an estimated $411K.
  • Viatris made up 2% of Delek Group's portfolio in Q2 2019, its #5 holding.
  • Delek Group first reported a position in Viatris in Q4 2017 and has held it in 7 quarters since.
  • Delek Group's Viatris position peaked at $105M in Q3 2018.
  • 439 funds tracked by Wall St. Rank held Viatris as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.